GlassScriptPhysician profile
John A Losurdo
NPI 1770859316
$1,258.93
in general payments reported to CMS, 2019-2025
12 companies · $331 in 2025
The $331 reported for 2025 was more than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $16.23 · 2021: $96.79 · 2022: $74.17 · 2023: $377 · 2024: $364 · 2025: $331.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,072.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,071.74 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Organogenesis INC. | $698.89 | 2023-2025 | Puraply, Puraply Wound Matrix, Affinity |
| Tela Bio, INC. | $195.04 | 2025 | Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex) |
| Intuitive Surgical, INC. | $106.18 | 2021-2024 | |
| Advanced Oxygen Therapy INC. | $61.81 | 2021-2025 | Topical Oxygen Chamber For Extremities |
| Merit Medical Systems INC | $61.00 | 2021 | |
| Bard Peripheral Vascular, INC. | $23.89 | 2022 | |
| Veryan Medical Incorporated | $21.52 | 2023 | Biomimics 3d Vascular Stent System |
| Innovation Technologies INC | $21.41 | 2023 | Irrisept |
| Acera Surgical, INC. | $19.96 | 2022 | |
| Medtronic, INC. | $17.23 | 2022 | |
| Merck Sharp & Dohme LLC | $16.23 | 2019 | |
| Eagle Pharmaceuticals, INC. | $15.77 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Losurdo listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.